Tyratech, inc last week announced a successful share offering along with deals for distribution of its head lice products with UK chemist chains.
The share placing raised £3.5m, and will be used in part to launch the Vamousse head lice product in Superdrug and Boots stores in the UK, following on from successful agreements in the US.
Bruno Jactel, Chief Executive Officer, explained that this move was ahead of expectations for the company: "Due in part to the success and interest generated in the USA, TyraTech has been able to capitalise on opportunities in the UK market in a shorter timeframe than was previously envisaged."
VaMousse was registered in the UK in 2012.